A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma
一项针对无法切除的原发性或复发性头颈部鳞状细胞癌患者的西妥昔单抗联合白细胞介素-12治疗的I/II期临床试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-2108
McMichael, Elizabeth L; Benner, Brooke; Atwal, Lakhvir S; Courtney, Nicholas B; Mo, Xiaokui; Davis, Melanie E; Campbell, Amanda R; Duggan, Megan C; Williams, Kallan; Martin, Kyle; Levine, Kala; Olaverria Salavaggione, Gonzalo N; Noel, Tiffany; Ganju, Akaansha; Uppati, Sarvani; Paul, Bonnie; Olencki, Thomas; Teknos, Theodoros N; Savvides, Panos; Tridandapani, Susheela; Byrd, John C; Caligiuri, Michael A; Liu, Stephen V; Carson, William E 3rd
